Literature DB >> 26786947

Detection of isoniazid and rifampin resistance of Mycobacteriumtuberculosis by a multiplex allele-specific polymerase chain reaction (PCR) assay.

Zeyneb Allegui1, Asma Ghariani2, Henda Draoui3, Ameni Ghezal3, Emna Mehiri2, Leila Slim-Saidi4.   

Abstract

BACKGROUND: The use of molecular techniques is a major improvement for the rapid routine detection and control of multidrug-resistant tuberculosis (MDR-TB). MATERIALS: In this study, the multiplex allele-specific polymerase chain reaction (MAS-PCR) was developed to simultaneously detect the most frequent mutations associated with isoniazid (INH) and rifampin (RIF) resistance in a single assay.
RESULTS: The assay was tested with 53 clinical isolates. Among them, 27 were MDR strains, 17 were mono-resistant to INH, one was mono-resistant to RIF, and eight were susceptible. The MAS-PCR assay showed a specificity of 100% in detecting drug resistance. An equivalent sensitivity of 92.6% in detecting MDR and RIF-resistance was found. The sensitivity for the detection of INH-resistance was 88.6%.
CONCLUSIONS: The MAS-PCR assay was a simple and rapid method for detecting the INH and RIF-resistance in Mycobacterium tuberculosis (MT) clinical strains. It is also easy to perform and to interpret. The assay is inexpensive and a less-demanding technique.
Copyright © 2012 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Multidrug-resistant; Multiplex PCR; Mutations; Tuberculosis

Year:  2012        PMID: 26786947     DOI: 10.1016/j.ijmyco.2012.01.006

Source DB:  PubMed          Journal:  Int J Mycobacteriol        ISSN: 2212-5531


  2 in total

1.  Novel mutations detected from drug resistant Mycobacterium tuberculosis isolated from North East of Thailand.

Authors:  Ei Phoo Thwe; Wises Namwat; Porntip Pinlaor; Kulrattana Rueangsak; Arunnee Sangka
Journal:  World J Microbiol Biotechnol       Date:  2021-10-13       Impact factor: 3.312

2.  Rapid detection of drug-resistant Mycobacterium tuberculosis directly from clinical specimens using allele-specific polymerase chain reaction assay.

Authors:  Pallavi Sinha; Tuhina Banerjee; G N Srivastava; Shampa Anupurba
Journal:  Indian J Med Res       Date:  2019-07       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.